128 related articles for article (PubMed ID: 12705974)
21. An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.
Weller DR; Brundage RC; Balfour HH; Vezina HE
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):369-73. PubMed ID: 17081812
[TBL] [Abstract][Full Text] [Related]
22. Determination of lopinavir and nevirapine by high-performance liquid chromatography after solid-phase extraction: application for the assessment of their transplacental passage at delivery.
Marzolini C; Béguin A; Telenti A; Schreyer A; Buclin T; Biollaz J; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jul; 774(2):127-40. PubMed ID: 12076682
[TBL] [Abstract][Full Text] [Related]
23. Conventional HPLC method used for simultaneous determination of the seven HIV protease inhibitors and nonnucleoside reverse transcription inhibitor efavirenz in human plasma.
Takahashi M; Yoshida M; Oki T; Okumura N; Suzuki T; Kaneda T
Biol Pharm Bull; 2005 Jul; 28(7):1286-90. PubMed ID: 15997115
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous determination of 16 anti-HIV drugs in human plasma by high-performance liquid chromatography.
Notari S; Bocedi A; Ippolito G; Narciso P; Pucillo LP; Tossini G; Donnorso RP; Gasparrini F; Ascenzi P
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):258-66. PubMed ID: 16406832
[TBL] [Abstract][Full Text] [Related]
25. A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.
D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Oddone V; Stefani FR; Agati S; Cusato J; Bonora S; Di Perri G
J Pharm Biomed Anal; 2011 Mar; 54(4):779-88. PubMed ID: 21071165
[TBL] [Abstract][Full Text] [Related]
26. Automated, fast, and sensitive quantification of drugs in human plasma by LC/LC-MS: quantification of 6 protease inhibitors and 3 nonnucleoside transcriptase inhibitors.
Egge-Jacobsen W; Unger M; Niemann CU; Baluom M; Hirai S; Benet LZ; Christians U
Ther Drug Monit; 2004 Oct; 26(5):546-62. PubMed ID: 15385839
[TBL] [Abstract][Full Text] [Related]
27. Simultaneous determination of 8 HIV protease inhibitors in human plasma by isocratic high-performance liquid chromatography with combined use of UV and fluorescence detection: amprenavir, indinavir, atazanavir, ritonavir, lopinavir, saquinavir, nelfinavir and M8-nelfinavir metabolite.
Verbesselt R; Van Wijngaerden E; de Hoon J
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jan; 845(1):51-60. PubMed ID: 16997640
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous determination of the five HIV-protease inhibitors: amprenavir, indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by solid-phase extraction and column liquid chromatography.
Poirier JM; Radembino N; Robidou P; Jaillon P
Ther Drug Monit; 2000 Aug; 22(4):465-73. PubMed ID: 10942189
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection.
van Heeswijk RP; Hoetelmans RM; Harms R; Meenhorst PL; Mulder JW; Lange JM; Beijnen JH
J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):159-68. PubMed ID: 9869376
[TBL] [Abstract][Full Text] [Related]
30. Validation of an electrospray ionization LC-MS/MS method for quantitative analysis of raltegravir, etravirine, and 9 other antiretroviral agents in human plasma samples.
Quaranta S; Woloch C; Paccou A; Giocanti M; Solas C; Lacarelle B
Ther Drug Monit; 2009 Dec; 31(6):695-702. PubMed ID: 19865000
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography.
Sarasa-Nacenta M; López-Púa Y; Mallolas J; Blanco JL; Gatell JM; Carné X
J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(2):325-32. PubMed ID: 11417878
[TBL] [Abstract][Full Text] [Related]
32. Reverse phase high-performance liquid chromatography method for the analysis of amprenavir, efavirenz, indinavir, lopinavir, nelfinavir and its active metabolite (M8), ritonavir, and saquinavir in heparinized human plasma.
Keil K; Frerichs VA; DiFrancesco R; Morse G
Ther Drug Monit; 2003 Jun; 25(3):340-6. PubMed ID: 12766563
[TBL] [Abstract][Full Text] [Related]
33. A less sensitive detector does not necessarily result in a less sensitive method: fast quantification of 13 antiretroviral analytes in plasma with liquid chromatography coupled with tandem mass spectrometry.
Ter Heine R; Rosing H; Beijnen JH; Huitema AD
Clin Chem Lab Med; 2010 Aug; 48(8):1153-5. PubMed ID: 20482447
[TBL] [Abstract][Full Text] [Related]
34. High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
Choi SO; Rezk NL; Kashuba AD
J Pharm Biomed Anal; 2007 Mar; 43(4):1562-7. PubMed ID: 17236737
[TBL] [Abstract][Full Text] [Related]
35. Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatography coupled with tandem mass spectrometry.
ter Heine R; Davids M; Rosing H; van Gorp EC; Mulder JW; van der Heide YT; Beijnen JH; Huitema AD
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(5-6):575-80. PubMed ID: 19168402
[TBL] [Abstract][Full Text] [Related]
36. Sensitive and rapid method for the simultaneous quantification of the HIV-protease inhibitors indinavir, nelfinavir, ritonavir, and saquinavir in human plasma by reversed-phase liquid chromatography.
Bouley M; Briere C; Padoin C; Petitjean O; Tod M
Ther Drug Monit; 2001 Feb; 23(1):56-60. PubMed ID: 11206045
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous HPLC assay for quantification of indinavir, nelfinavir, ritonavir, and saquinavir in human plasma.
Remmel RP; Kawle SP; Weller D; Fletcher CV
Clin Chem; 2000 Jan; 46(1):73-81. PubMed ID: 10620574
[TBL] [Abstract][Full Text] [Related]
38. Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography.
Aymard G; Legrand M; Trichereau N; Diquet B
J Chromatogr B Biomed Sci Appl; 2000 Jul; 744(2):227-40. PubMed ID: 10993510
[TBL] [Abstract][Full Text] [Related]
39. High-performance liquid chromatography assay for the quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in human plasma.
Rezk NL; Tidwell RR; Kashuba AD
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jun; 805(2):241-7. PubMed ID: 15135096
[TBL] [Abstract][Full Text] [Related]
40. Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction.
Colombo S; Guignard N; Marzolini C; Telenti A; Biollaz J; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(1):25-34. PubMed ID: 15358304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
